Position in ALKS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$83,081,142
+$19,978,359 QoQ
Shares Held
1,585,518
-11.2% QoQ
Ownership
0.945%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#27
of 423 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026LOOMIS SAYLES & CO L P holds $224,982,288 across 8 Drug Manufacturers - Specialty & Generic names. ALKS ranks #1 (36.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
This page
|
1,585,518 | $83,081,142 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,475,192 | $68,611,179 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
182,514 | $30,760,908 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
141,424 | $15,689,578 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
162,792 | $13,475,921 | |
| 6 | COLL |
Collegium Pharmaceutical, Inc
|
364,999 | $13,212,963 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
255 | $138,166 | |
| 8 | ZTS |
Zoetis Inc.
|
173 | $12,431 |
All Filings in ALKS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $83,081,142 | 1,585,518 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $63,102,783 | 1,784,581 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $53,232,564 | 1,902,522 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $61,465,530 | 2,048,851 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $60,364,067 | 2,109,894 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $80,578,144 | 2,440,283 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $66,231,547 | 2,302,905 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $52,703,378 | 1,882,936 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $9,748,787 | 404,514 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $20,764,773 | 767,077 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $21,420,744 | 772,197 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $19,212,814 | 685,927 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $11,518,619 | 368,007 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $9,330,720 | 330,994 | Shares | Defined | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||